Directory of TB vaccine clinical trial sites

There are approximately 14 vaccine candidates for tuberculosis (TB). Over the upcoming 10 years these need to be tested in clinical trials. To support the identification of suitable trial sites, KNCV Tuberculosis Foundation joined forces with TBVI to develop a directory of clinical trial sites in sub-Saharan Africa.

This directory provides a comprehensive overview of trial sites and their capacity to conduct studies on TB vaccines. The directory was commissioned by EDCTP and developed by KNCV and TBVI.

EDCTP just published the clinical trial site on TB vaccines on their website. It can be found here.

 

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.